NovoCure (NVCR) Inventory (2014 - 2026)

NovoCure's Inventory history runs 13 years deep, the most recent figure standing at $43.5 million for Q1 2026.

• In Q1 2026, Inventory rose 10.11% year-over-year to $43.5 million; the TTM figure through Mar 2026 stood at $43.5 million (up 10.11% YoY), while the FY2025 annual figure was $41.1 million, up 17.17% from the prior year.
• Inventory came in at $43.5 million for Q1 2026 at NovoCure, up from $41.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $43.5 million in Q1 2026 to a low of $26.8 million in Q3 2022.
• A 5-year average of $36.2 million and a median of $38.2 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 37.38% in 2023 and fell 8.04% in 2024, its largest moves.
• NovoCure's Inventory stood at $29.4 million in 2022, then increased by 29.87% to $38.2 million in 2023, then decreased by 8.04% to $35.1 million in 2024, then advanced by 17.17% to $41.1 million in 2025, then grew by 5.71% to $43.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $43.5 million, $41.1 million, and $39.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison